Developing of Virtual Reality Based Neurologic Examination Teaching

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Clinical Trial Summary

The purpose of this study is to evaluate the effect of the virtual reality based neurologic examination teaching tool(VRNET) for medical students. VRNET is a new teaching tool for neurologic examinations by offering different neurologic signs of the face, with which medical students can experience more realistic patients.

See also
Status	Clinical Trial	Phase
Active, not recruiting	`NCT05817682` - Interprofessional Education of Medical Students Using Medical Simulation	N/A
Completed	`NCT05123573` - Self-Perceived in Medical Students Undergoing Distance Learning
Recruiting	`NCT05807828` - VR Simulation and Basic Skills in THA	N/A
Recruiting	`NCT06037616` - Teaching Simple Skin Sutures to Medical Students	N/A

NCT number	NCT03653221
Study type	Interventional
Source	Yonsei University
Contact
Status	Completed
Phase	N/A
Start date	March 18, 2019
Completion date	July 12, 2019

Developing of Virtual Reality Based Neurologic Examination Teaching Tool(VRNET)

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms